Correlation Between Hyrican Informationssyst and Avanos Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hyrican Informationssyst and Avanos Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hyrican Informationssyst and Avanos Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hyrican Informationssysteme Aktiengesellschaft and Avanos Medical, you can compare the effects of market volatilities on Hyrican Informationssyst and Avanos Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hyrican Informationssyst with a short position of Avanos Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hyrican Informationssyst and Avanos Medical.

Diversification Opportunities for Hyrican Informationssyst and Avanos Medical

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Hyrican and Avanos is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Hyrican Informationssysteme Ak and Avanos Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avanos Medical and Hyrican Informationssyst is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hyrican Informationssysteme Aktiengesellschaft are associated (or correlated) with Avanos Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avanos Medical has no effect on the direction of Hyrican Informationssyst i.e., Hyrican Informationssyst and Avanos Medical go up and down completely randomly.

Pair Corralation between Hyrican Informationssyst and Avanos Medical

Assuming the 90 days horizon Hyrican Informationssysteme Aktiengesellschaft is expected to generate 1.05 times more return on investment than Avanos Medical. However, Hyrican Informationssyst is 1.05 times more volatile than Avanos Medical. It trades about 0.02 of its potential returns per unit of risk. Avanos Medical is currently generating about -0.01 per unit of risk. If you would invest  496.00  in Hyrican Informationssysteme Aktiengesellschaft on October 5, 2024 and sell it today you would earn a total of  34.00  from holding Hyrican Informationssysteme Aktiengesellschaft or generate 6.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Hyrican Informationssysteme Ak  vs.  Avanos Medical

 Performance 
       Timeline  
Hyrican Informationssyst 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Hyrican Informationssysteme Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly fragile basic indicators, Hyrican Informationssyst may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Avanos Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avanos Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Hyrican Informationssyst and Avanos Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hyrican Informationssyst and Avanos Medical

The main advantage of trading using opposite Hyrican Informationssyst and Avanos Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hyrican Informationssyst position performs unexpectedly, Avanos Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avanos Medical will offset losses from the drop in Avanos Medical's long position.
The idea behind Hyrican Informationssysteme Aktiengesellschaft and Avanos Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets